18F NaF PET/CT in the Assessment of Metastatic Bone Disease
作者： Mohsen Beheshti , Werner Langsteger
DOI: 10.1016/J.CPET.2012.04.002
关键词:
摘要: The skeletal system is the third most common site of metastases after lungs and liver, 80% all reported metastatic bone disease in patients with breast prostate cancer. At present there are an unprecedented number novel molecular imaging agents potentially available for assessment different This review assesses role PET metastases, focusing on specific tracers (fluorodeoxyglucose, choline derivatives, so forth), comparison (18)F NaF as a nonspecific bone-seeking agent.
elsevier.com
sci-hub.se 参考文章(85)
Karin E. Limburg, Mary Ann Moran, Synthesis and Evaluation Springer, New York, NY. pp. 155- 172 ,(1986) , 10.1007/978-1-4612-4874-3_6
Christophe Van de Wiele, Filip De Vos, Guido Slegers, Simon Van Belle, Rudi Andre Dierckx, Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 27, pp. 1421- 1433 ,(2000) , 10.1007/S002590000305
M A Bender, M Blau, W Nagler, Fluorine-18: a new isotope for bone scanning. The Journal of Nuclear Medicine. ,vol. 3, pp. 332- 334 ,(1962)
F. Rossi, M. Grzeskowiak, V. Della Bianca, A. Sbarbati, De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of beta-glucan particles. Journal of Biological Chemistry. ,vol. 266, pp. 8034- 8038 ,(1991) , 10.1016/S0021-9258(18)92935-2
David W. Golde, Carlos Cordon-Cardo, George Sgouros, Ase Ballangrud, Howard I. Scher, David B. Agus, Positron Emission Tomography of a Human Prostate Cancer Xenograft: Association of Changes in Deoxyglucose Accumulation with Other Measures of Outcome following Androgen Withdrawal Cancer Research. ,vol. 58, pp. 3009- 3014 ,(1998)
David T. Price, Cary N. Robertson, Steven W. Baldwin, Matthew D. Orr, R. Edward Coleman, Thomas J. Polascik, Shuyan Wang, Timothy R. DeGrado, Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Research. ,vol. 61, pp. 110- 117 ,(2001)
Karin Nüssle, Albrecht Guhlmann, Sven N. Reske, Holger Schirrmeister, Klaus Elsner, Jörg Kotzerke, Bernd Neumaier, Harald Träger, Marion Rentschler, Gerhard Glatting, Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. The Journal of Nuclear Medicine. ,vol. 40, pp. 1623- 1629 ,(1999)
Milton D. Gross, Paul D. Shreve, Imaging of the pancreas and related diseases with PET carbon-11-acetate The Journal of Nuclear Medicine. ,vol. 38, pp. 1305- 1310 ,(1997)
Sven Perner, Norbert M Blumstein, Sven N Reske, Frank Finsterbusch, Darius Kocot, Peter Möller, Bernd Neumaier, Hans-Werner Gottfried, Gerhard Glatting, Imaging Prostate Cancer with 11C-Choline PET/CT The Journal of Nuclear Medicine. ,vol. 47, pp. 1249- 1254 ,(2006)
M. D. Gross, M. Schwaiger, P. Shreve, H. D. Humes, Ping-Chun Chiao, Carbon-11-Acetate PET Imaging in Renal Disease The Journal of Nuclear Medicine. ,vol. 36, pp. 1595- 1601 ,(1995)